Cupps Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-10,390
Closed -$834K 182
2015
Q3
$834K Sell
10,390
-20,798
-67% -$1.67M 0.11% 122
2015
Q2
$3.74M Buy
31,188
+1,545
+5% +$185K 0.36% 91
2015
Q1
$3.1M Buy
29,643
+4,454
+18% +$465K 0.28% 98
2014
Q4
$2.44M Sell
25,189
-82,737
-77% -$8.02M 0.22% 110
2014
Q3
$8.43M Sell
107,926
-21,727
-17% -$1.7M 0.78% 44
2014
Q2
$8.19M Buy
129,653
+34,806
+37% +$2.2M 0.66% 57
2014
Q1
$6.37M Sell
94,847
-7,476
-7% -$502K 0.49% 72
2013
Q4
$6.58M Buy
102,323
+344
+0.3% +$22.1K 0.45% 76
2013
Q3
$6.53M Buy
+101,979
New +$6.53M 0.42% 74